Final Agenda Now Available

Targeting Innate Immunity Congress
-先天性免疫标靶学会-
日期:2019年9月23-25日
地点:美国马萨诸塞州剑桥市,Hyatt Regency Cambridge
Choose your language
Chinese
Japanese
Korean
English


关于Targeting Innate Immunity Congress

尽管过往有关先天性免疫研究的进展不多,近年已认识到其作为治疗干预的具潜力工具的重要性。第1届Targeting Innate Immunity Congress将齐聚相关意见领袖,包含产业专家、学术研究人员、医师等,一同深入了解先天性免疫、以及如何利用其力量进行有效的免疫治疗。为期2天的会议聚焦先天免疫治疗领域的现况和新发展,如自然杀手细胞、巨噬细胞、树状细胞等。并讨论先天免疫的作用机制、有效调节策略、肿瘤微环境影响等议题。您可在融洽的环境中和与会者交流创新想法、推动有意义的合作。在本学会中您可接触到先天免疫社群最新成果,是透过交换情报和吸收新知拓展业务策略成果的重要基石。

2019主要演讲者

Michael Klichinsky, PharmD, PhD
Co-Founder, Vice President, Carisma Therapeutics

Hans Klingemann, MD, PhD
Vice President, NantKwest, Inc.

Mark Lowdell, PhD
Director, Centre for Cell, Gene & Tissue Therapeutics, RFH; Professor, University College London

Shiladitya Sengupta, PhD
Principle Investigator, Harvard Medical School and Massachusetts Institute of Technology

RJ Tesi, MD
CEO, CMO, INmune Bio

Bob Valamehr, PhD
MBA, Chief Development Officer, Fate Therapeutics, Inc.



Technology Hub of the Boston Area
Cambridge, Massachusetts

The city of Cambridge, part of the Greater Boston area, is best known for being the home of two world-class universities, Harvard University and Massachusetts Institute of Technology (MIT). MIT is located in the heart of Technology Square, an area consisting of 7 major buildings forming a quadrangle with a combined 1 million-plus square feet of office, lab, and retail space. Surrounding Technology Square are other major tech and life science companies like Amgen, Inc., Akamai Technologies, Twitter, Novartis International AG, The Whitehead Institute, Schlumberger-Doll, and the Charles Stark Draper Laboratory. Cambridge prides itself on being a progressive community, enjoying both a rich history and an open eye toward the future. We hope you will join us to explore this charming city on the leading edge of technology.

Corporate Sponsors:
 
免费电子邮件通知服务